S&P 500   5,105.34 (+0.18%)
DOW   38,916.63 (-0.20%)
QQQ   440.63 (+0.37%)
AAPL   180.10 (-0.36%)
MSFT   413.87 (+0.06%)
META   498.27 (+1.66%)
GOOGL   138.04 (-0.30%)
AMZN   176.71 (-0.03%)
TSLA   199.52 (-1.17%)
NVDA   802.95 (+1.50%)
NIO   5.70 (-0.87%)
AMD   198.19 (+2.94%)
BABA   74.94 (+1.23%)
T   16.88 (-0.30%)
F   12.36 (-0.64%)
MU   94.28 (+4.05%)
CGC   3.22 (-2.13%)
GE   157.64 (+0.48%)
DIS   111.50 (-0.07%)
AMC   4.28 (-0.93%)
PFE   26.61 (+0.19%)
PYPL   61.00 (+1.09%)
XOM   105.87 (+1.29%)
S&P 500   5,105.34 (+0.18%)
DOW   38,916.63 (-0.20%)
QQQ   440.63 (+0.37%)
AAPL   180.10 (-0.36%)
MSFT   413.87 (+0.06%)
META   498.27 (+1.66%)
GOOGL   138.04 (-0.30%)
AMZN   176.71 (-0.03%)
TSLA   199.52 (-1.17%)
NVDA   802.95 (+1.50%)
NIO   5.70 (-0.87%)
AMD   198.19 (+2.94%)
BABA   74.94 (+1.23%)
T   16.88 (-0.30%)
F   12.36 (-0.64%)
MU   94.28 (+4.05%)
CGC   3.22 (-2.13%)
GE   157.64 (+0.48%)
DIS   111.50 (-0.07%)
AMC   4.28 (-0.93%)
PFE   26.61 (+0.19%)
PYPL   61.00 (+1.09%)
XOM   105.87 (+1.29%)
S&P 500   5,105.34 (+0.18%)
DOW   38,916.63 (-0.20%)
QQQ   440.63 (+0.37%)
AAPL   180.10 (-0.36%)
MSFT   413.87 (+0.06%)
META   498.27 (+1.66%)
GOOGL   138.04 (-0.30%)
AMZN   176.71 (-0.03%)
TSLA   199.52 (-1.17%)
NVDA   802.95 (+1.50%)
NIO   5.70 (-0.87%)
AMD   198.19 (+2.94%)
BABA   74.94 (+1.23%)
T   16.88 (-0.30%)
F   12.36 (-0.64%)
MU   94.28 (+4.05%)
CGC   3.22 (-2.13%)
GE   157.64 (+0.48%)
DIS   111.50 (-0.07%)
AMC   4.28 (-0.93%)
PFE   26.61 (+0.19%)
PYPL   61.00 (+1.09%)
XOM   105.87 (+1.29%)
S&P 500   5,105.34 (+0.18%)
DOW   38,916.63 (-0.20%)
QQQ   440.63 (+0.37%)
AAPL   180.10 (-0.36%)
MSFT   413.87 (+0.06%)
META   498.27 (+1.66%)
GOOGL   138.04 (-0.30%)
AMZN   176.71 (-0.03%)
TSLA   199.52 (-1.17%)
NVDA   802.95 (+1.50%)
NIO   5.70 (-0.87%)
AMD   198.19 (+2.94%)
BABA   74.94 (+1.23%)
T   16.88 (-0.30%)
F   12.36 (-0.64%)
MU   94.28 (+4.05%)
CGC   3.22 (-2.13%)
GE   157.64 (+0.48%)
DIS   111.50 (-0.07%)
AMC   4.28 (-0.93%)
PFE   26.61 (+0.19%)
PYPL   61.00 (+1.09%)
XOM   105.87 (+1.29%)
OTCMKTS:ERFSF

Eurofins Scientific (ERFSF) Stock Price, News & Analysis

$59.63
+0.39 (+0.65%)
(As of 02/29/2024 ET)
Today's Range
$59.63
$60.65
50-Day Range
$57.88
$67.16
52-Week Range
$47.14
$72.39
Volume
1,283 shs
Average Volume
1,955 shs
Market Capitalization
$11.48 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ERFSF stock logo

About Eurofins Scientific Stock (OTCMKTS:ERFSF)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 130,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; and testing for persistent organic pollutants, dioxins and organic contaminants, pesticides, mycotoxins, allergens, and pathogens and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

ERFSF Stock Price History

ERFSF Stock News Headlines

Eurofins Scientific reports FY results
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
Giverny Capital Asset Management Q4 2023 Letter
Eurofins Scientific SE (0MV5)
Eurofins Scientific
See More Headlines
Receive ERFSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:ERFSF
Previous Symbol
NASDAQ:ERFSF
CIK
N/A
Employees
55,631
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.05 billion
Cash Flow
$6.57 per share
Book Value
$26.56 per share

Miscellaneous

Free Float
N/A
Market Cap
$11.48 billion
Optionable
Not Optionable
Beta
0.74
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Dr. Gilles G. Martin Ph.D. (Age 61)
    Chairman of the Board & CEO
    Comp: $1.37M
  • Ms. Valerie Hanote (Age 58)
    Executive Director
    Comp: $390.22k
  • Mr. Laurent Lebras
    Group Administration & Finance Director
  • Ms. Sandra Hoeylaerts
    Chief Human Resources Officer
  • Mr. David W. Bryant
    Senior VP of Strategic Business Development North America
  • Mr. Gabriel Julia
    Senior VP of Clinical Diagnostics Europe
  • Dr. Timothy S. Oostdyk
    Executive VP of BioPharma, Genomics & Agrosciences Services North America
  • Mr. Joachim Reichelt
    Senior Vice President of Food & Feed Testing Europe
  • Ms. Yvoine Remy
    Senior Vice President of Environment Testing Europe
  • Mr. Francois Vigneau
    Senior Vice President of Food & Feed Testing - Western Europe














ERFSF Stock Analysis - Frequently Asked Questions

Should I buy or sell Eurofins Scientific stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last twelve months. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" ERFSF shares.
View ERFSF analyst ratings
or view top-rated stocks.

How have ERFSF shares performed in 2024?

Eurofins Scientific's stock was trading at $64.31 at the beginning of the year. Since then, ERFSF stock has decreased by 7.3% and is now trading at $59.63.
View the best growth stocks for 2024 here
.

Are investors shorting Eurofins Scientific?

Eurofins Scientific saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 378,900 shares, an increase of 10.4% from the January 31st total of 343,200 shares. Based on an average trading volume of 1,900 shares, the short-interest ratio is currently 199.4 days.
View Eurofins Scientific's Short Interest
.

How do I buy shares of Eurofins Scientific?

Shares of ERFSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ERFSF) was last updated on 3/1/2024 by MarketBeat.com Staff